Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
876.5 CHF | -0.40% | -0.45% | +2.39% |
Apr. 02 | Health Care Down on Flight From Risk -- Health Care Roundup | DJ |
Apr. 02 | European Midday Briefing : Stocks Gain as Bonds Track Treasuries Lower | DJ |
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The firm trades with high earnings multiples: 25.41 times its 2024 earnings per share.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.39% | 4.15B | B+ | ||
+37.78% | 723B | C+ | ||
+31.21% | 598B | B | ||
-3.51% | 364B | C+ | ||
+19.94% | 331B | B- | ||
+5.14% | 288B | C+ | ||
+16.30% | 244B | B+ | ||
-4.46% | 208B | A+ | ||
+9.89% | 210B | B- | ||
+9.32% | 169B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SFZN Stock
- Ratings Siegfried Holding AG